A number of epidemiological studies have demonstrated that non-functional CCR5 is associated not only with lower HIV transmission, but also with the reduced severity rheumatoid arthritis (RA) and/or a lower frequency of RA development13–17, collectively suggesting that CCR5 is a suitable target for RA therapy. The gene discussed is CCR5; the disease is rheumatoid arthritis.